(Q35837790)

10 August 2017

1 reference

title

Impact of 'ome' analyses on inverse metabolic engineering (English)

1 reference

10 August 2017

2

1 reference

10 August 2017

Christoffer Bro

1

1 reference

10 August 2017

1 July 2004

1 reference

10 August 2017

Metabolic Engineering

1 reference

10 August 2017

6

1 reference

10 August 2017

3

1 reference

10 August 2017

204-211

1 reference

Mass spectrometry-based proteomics

10 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2003.11.005

Integrating transcriptional and metabolite profiles to direct the engineering of lovastatin-producing fungal strains.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2003.11.005

Lessons from metabolic engineering for functional genomics and drug discovery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2003.11.005

Reflections on the scope and the future of metabolic engineering and its connections to functional genomics and drug discovery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2003.11.005

Inverse metabolic engineering: A strategy for directed genetic engineering of useful phenotypes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2003.11.005

The genome-wide transcriptional responses of Saccharomyces cerevisiae grown on glucose in aerobic chemostat cultures limited for carbon, nitrogen, phosphorus, or sulfur.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2003.11.005

Transcriptional, proteomic, and metabolic responses to lithium in galactose-grown yeast cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2003.11.005

Genome-wide transcriptional response of a Saccharomyces cerevisiae strain with an altered redox metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2003.11.005

The commercial production of chemicals using pathway engineering

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2003.11.005

Metabolic characterization of high- and low-yielding strains of Penicillium chrysogenum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2003.11.005

Comparative genotyping of the Saccharomyces cerevisiae laboratory strains S288C and CEN.PK113-7D using oligonucleotide microarrays.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2003.11.005

Purification and Properties of Phosphoglucomutase from Fleischmann's Yeast

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2003.11.005

Genome microarray analysis of transcriptional activation in multidrug resistance yeast mutants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2003.11.005

Systematic changes in gene expression patterns following adaptive evolution in yeast

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2003.11.005

Metabolite profiling for plant functional genomics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2003.11.005

A functional genomics approach using metabolomics andin silicopathway analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2003.11.005

Genome-scale reconstruction of the Saccharomyces cerevisiae metabolic network

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2003.11.005

Gene array-based identification of changes that contribute to ethanol tolerance in ethanologenic Escherichia coli: comparison of KO11 (parent) to LY01 (resistant mutant).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2003.11.005

Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2003.11.005

Proteome analysis of metabolically engineered Escherichia coli producing Poly(3-hydroxybutyrate).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2003.11.005

Hap4p overexpression in glucose-grown Saccharomyces cerevisiae induces cells to enter a novel metabolic state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2003.11.005

Understanding the growth phenotype of the yeast gcr1 mutant in terms of global genomic expression patterns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2003.11.005

An expanded role for microbial physiology in metabolic engineering and functional genomics: moving towards systems biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2003.11.005

Transcription of a yeast phosphoglucomutase isozyme gene is galactose inducible and glucose repressible

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2003.11.005

A novel methodology employing Corynebacterium glutamicum genome information to generate a new L-lysine-producing mutant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2003.11.005

Increasing galactose consumption by Saccharomyces cerevisiae through metabolic engineering of the GAL gene regulatory network

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2003.11.005

Proteomics to study genes and genomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2003.11.005

Metabolic consequences of altered phosphoenolpyruvate carboxykinase activity in Corynebacterium glutamicum reveal anaplerotic regulation mechanisms in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2003.11.005

Reproducibility of oligonucleotide microarray transcriptome analyses. An interlaboratory comparison using chemostat cultures of Saccharomyces cerevisiae.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2003.11.005

A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2003.11.005

Genomics to fluxomics and physiomics — pathway engineering

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2003.11.005

Metabolic engineering as an integrating platform for strain development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2003.11.005

13C-NMR, MS and metabolic flux balancing in biotechnology research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2003.11.005

Gene discovery via metabolic profiling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2003.11.005

Molecular analysis of a Saccharomyces cerevisiae mutant with improved ability to utilize xylose shows enhanced expression of proteins involved in transport, initial xylose metabolism, and the pentose phosphate pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2003.11.005

Accurate determination of 13C enrichments in nonprotonated carbon atoms of isotopically enriched amino acids by 1H nuclear magnetic resonance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2003.11.005

Isolation and characterization of ethanol-tolerant mutants of Escherichia coli KO11 for fuel ethanol production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2003.11.005

Functional genomics: expression analysis of Escherichia coli growing on minimal and rich media

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2003.11.005

inferred from DOI database lookup

7 January 2021

based on heuristic

Genome-wide transcriptional analysis of aerobic and anaerobic chemostat cultures of Saccharomyces cerevisiae

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2003.11.005

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YMBEN.2003.11.005

1 reference

10 August 2017

1 reference

PubMed ID

15256210